BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28147269)

  • 1. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.
    Ishigaki S; Fujioka Y; Okada Y; Riku Y; Udagawa T; Honda D; Yokoi S; Endo K; Ikenaka K; Takagi S; Iguchi Y; Sahara N; Takashima A; Okano H; Yoshida M; Warita H; Aoki M; Watanabe H; Okado H; Katsuno M; Sobue G
    Cell Rep; 2017 Jan; 18(5):1118-1131. PubMed ID: 28147269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
    Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
    Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aberrant Interaction Between FUS and SFPQ in Neurons in a Wide Range of FTLD Spectrum Diseases].
    Ishigaki S
    Brain Nerve; 2021 Sep; 73(9):1021-1028. PubMed ID: 34462374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing.
    Orozco D; Tahirovic S; Rentzsch K; Schwenk BM; Haass C; Edbauer D
    EMBO Rep; 2012 Aug; 13(8):759-64. PubMed ID: 22710833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
    Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
    PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Functional Loss of FUS in FTLD/ALS.
    Ishigaki S; Sobue G
    Front Mol Biosci; 2018; 5():44. PubMed ID: 29774215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
    Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
    Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
    Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
    Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.
    Orozco D; Edbauer D
    J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
    Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
    Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
    Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.
    Josephs KA; Whitwell JL; Parisi JE; Petersen RC; Boeve BF; Jack CR; Dickson DW
    Eur J Neurol; 2010 Jul; 17(7):969-75. PubMed ID: 20236174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau isoform regulation is region- and cell-specific in mouse brain.
    McMillan P; Korvatska E; Poorkaj P; Evstafjeva Z; Robinson L; Greenup L; Leverenz J; Schellenberg GD; D'Souza I
    J Comp Neurol; 2008 Dec; 511(6):788-803. PubMed ID: 18925637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
    Lourenco GF; Janitz M; Huang Y; Halliday GM
    Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
    de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
    J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.
    Fujioka Y; Ishigaki S; Masuda A; Iguchi Y; Udagawa T; Watanabe H; Katsuno M; Ohno K; Sobue G
    Sci Rep; 2013; 3():2388. PubMed ID: 23925123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pathological subtypes of FTLD-FUS.
    Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
    Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.